ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higham, M.
Right arrow Articles by Morrell, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higham, M.
Right arrow Articles by Morrell, N.
Eur Respir J 2000; 15: 281-284
Copyright © ERS Journals Ltd 2000

Original Articles

Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease

MA Higham, NB Pride, A Alikhan, and NW Morrell

Tumour necrosis factor(TNF)-alpha levels are elevated in airways of patients with chronic obstructive pulmonary disease (COPD) and may contribute to its pathogenesis. A guanine to adenine substitution at position -308 of the TNF-alpha gene promoter (TNF1/2) has been associated with chronic bronchitis of various aetiologies in a Taiwanese population. The authors performed a study investigating association of the polymorphism with smoking-related COPD in Caucasians. Frequencies of TNF1/2 alleles in 86 Caucasians (52 males) with COPD were compared with 63 (52 males) asymptomatic smoker/exsmoker control subjects and a population control of 199 (99 males) blood donors. Genotyping was performed by the polymerase chain reaction-restriction fragment length polymorphism technique on genomic deoxyribonucleic acid (DNA) obtained from peripheral blood. There were no significant differences in TNF1/2 allele frequencies between groups: 0.85/0.15 in COPD, 0.85/0.15 in smoker control subjects, 0.83/0.17 in population control subjects. Within the COPD group there was no association of TNF1/2 alleles with indices of airflow obstruction (% predicted forced expiratory volume in one second (FEV1) and % predicted FEV1/vital capacity ratio) nor gas transfer (% predicted carbon monoxide transfer coefficient and % predicted carbon monoxide diffusing capacity of the lung). It is concluded that: 1) the tumour necrosis factor gene promoter allele does not influence the risk of developing chronic obstructive pulmonary disease in a Caucasian population of smokers; and 2) there is no association of the tumour necrosis factor gene promoter genotype with severity of airflow obstruction nor degree of emphysema in chronic obstructive pulmonary disease.


This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
J. Smolonska, C. Wijmenga, D. S. Postma, and H. M. Boezen
Meta-analyses on Suspected Chronic Obstructive Pulmonary Disease Genes: A Summary of 20 Years' Research
Am. J. Respir. Crit. Care Med., October 1, 2009; 180(7): 618 - 631.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
S J Marciniak and D A Lomas
What can naturally occurring mutations tell us about the pathogenesis of COPD?
Thorax, April 1, 2009; 64(4): 359 - 364.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
C. P. Hersh, D. L. DeMeo, and E. K. Silverman
National Emphysema Treatment Trial State of the Art: Genetics of Emphysema
Proceedings of the ATS, May 1, 2008; 5(4): 486 - 493.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. R. Gingo, L. J. Silveira, Y. E. Miller, A. L. Friedlander, G. P. Cosgrove, E. D. Chan, L. A. Maier, and R. P. Bowler
Tumour necrosis factor gene polymorphisms are associated with COPD
Eur. Respir. J., May 1, 2008; 31(5): 1005 - 1012.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Chappell, L. Daly, K. Morgan, T. G. Baranes, J. Roca, R. Rabinovich, A. Millar, S. C. Donnelly, V. Keatings, W. MacNee, et al.
Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD
Eur. Respir. J., October 1, 2007; 30(4): 810 - 812.
[Full Text] [PDF]

Home page
 Occup. Environ. Med.Home page
H. Zhang, J. Hang, X. Wang, W. Zhou, B. Sun, H. Dai, L. Su, and D. C Christiani
TNF polymorphisms modify endotoxin exposure-associated longitudinal lung function decline
Occup. Environ. Med., June 1, 2007; 64(6): 409 - 413.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
H. M. Boezen and D. S. Postma
Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression?
Eur. Respir. J., January 1, 2007; 29(1): 8 - 10.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Brogger, V. M. Steen, H. G. Eiken, A. Gulsvik, and P. Bakke
Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1.
Eur. Respir. J., April 1, 2006; 27(4): 682 - 688.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
R. Broekhuizen, R. F Grimble, W M. Howell, D. J Shale, E. C Creutzberg, E. F Wouters, and A. M Schols
Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1{beta} -511 single nucleotide polymorphism
Am. J. Clinical Nutrition, November 1, 2005; 82(5): 1059 - 1064.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. I. Rennard
Clinical Approach to Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Disease
Proceedings of the ATS, April 1, 2005; 2(1): 94 - 100.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J Yarden, D Radojkovic, K De Boeck, M Macek Jr, D Zemkova, V Vavrova, R Vlietinck, J-J Cassiman, and H Cuppens
Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype
Thorax, April 1, 2005; 60(4): 320 - 325.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
C E Ruse and S G Parker
Genetics and the Dutch Hypothesis
Chronic Respiratory Disease, April 1, 2004; 1(2): 105 - 113.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
I. Ferrarotti, M. Zorzetto, M. Beccaria, L.S. Gile, R. Porta, N. Ambrosino, P.F. Pignatti, I. Cerveri, E. Pozzi, and M. Luisetti
Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema
Eur. Respir. J., March 1, 2003; 21(3): 444 - 449.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
R Nadif, A Jedlicka, M Mintz, J-P Bertrand, S Kleeberger, and F Kauffmann
Effect of TNF and LTA polymorphisms on biological markers of response to oxidative stimuli in coal miners: a model of gene-environment interaction
J. Med. Genet., February 1, 2003; 40(2): 96 - 103.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Churg, J. Dai, H. Tai, C. Xie, and J. L. Wright
Tumor Necrosis Factor-{alpha} Is Central to Acute Cigarette Smoke-induced Inflammation and Connective Tissue Breakdown
Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 849 - 854.
[Abstract] [Full Text]

Home page
 ChestHome page
S. Sakao, K. Tatsumi, H. Igari, R. Watanabe, Y. Shino, H. Shirasawa, and T. Kuriyama
Association of Tumor Necrosis Factor-{alpha} Gene Promoter Polymorphism With Low Attenuation Areas on High-Resolution CT in Patients With COPD*
Chest, August 1, 2002; 122(2): 416 - 420.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A J Sandford and E K Silverman
Chronic obstructive pulmonary disease * 1: Susceptibility factors for COPD the genotype-environment interaction
Thorax, August 1, 2002; 57(8): 736 - 741.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. K. Silverman
Genetic Epidemiology of COPD
Chest, March 1, 2002; 121 (2009): 1S - 6S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.R. Hoidal
Genetics of COPD: present and future
Eur. Respir. J., November 1, 2001; 18(5): 741 - 743.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
K.F. Chung
Cytokines in chronic obstructive pulmonary disease
Eur. Respir. J., July 2, 2001; 18(34_suppl): 50S - 59s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. SAKAO, K. TATSUMI, H. IGARI, Y. SHINO, H. SHIRASAWA, and T. KURIYAMA
Association of Tumor Necrosis Factor {alpha} Gene Promoter Polymorphism with the Presence of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 420 - 422.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. J. SANDFORD, T. CHAGANI, T. D. WEIR, J. E. CONNETT, N. R. ANTHONISEN, and P. D. PARÉ
Susceptibility Genes for Rapid Decline of Lung Function in the Lung Health Study
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 469 - 473.
[Abstract] [Full Text]

Home page
 ChestHome page
S. Teramoto, T. Ishii, M. Luisetti, and P. F. Pignatti
No Association of Tumor Necrosis Factor-{{alpha}} Gene Polymorphism and COPD in Caucasian Smokers and Japanese Smokers
Chest, January 1, 2001; 119(1): 315 - 316.
[Full Text] [PDF]

Home page
 NEJMHome page
P. J. Barnes
Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., July 27, 2000; 343(4): 269 - 280.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the European Respiratory Society.